CoChat

Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation

Miron, Justin, Picard, Cynthia, Lafaille‐Magnan, Marie‐Élyse, Savard, Mélissa, Labonté, Anne, Breitner, John, Rosa‐Neto, Pedro, Auld, Daniel, Poirier, Judes, for the PREVENT‐AD research group · 2019 · Alzheimer's & Dementia
Cited by 37

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Introduction: A coding variant in the TLR4 receptor (rs4986790), previously associated with longevity and Alzheimer's disease (AD) risk reduction, was examined in a population isolate (Québec Founder Population [QFP]) and in presymptomatic individuals with a parental history of AD (Pre‐Symptomatic Evaluation of Novel or Experimental Treatment for Alzheimer's Disease [PREVENT‐AD]). Methods: Genotyping was performed using the Illumina HumanHap 550k (QFP) and the Illumina Omni2.5 beadchips (PREVENT‐AD). Cognition was assessed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS). Whole‐brain cortical thickness data were analyzed using CIVET 1.12. Cerebrospinal fluid concentrations of cytokines were obtained by using Milliplex. Results: The minor allele of the rs4986790 polymorphism (G) is associated with a reduced risk of developing AD in the QFP, as well as higher visuospatial and constructional abilities, higher cortical thickness in visual‐related regions, and stable cerebrospinal fluid IL‐1β levels in the PREVENT‐AD cohort. Discussion: The rs4986790 G coding variant in the TLR4 gene appears to reduce AD risk through the modulation of IL‐1β synthesis and secretion in the presymptomatic phase of the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.03.012

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 37

Metadata

Authors
Miron, J., Picard, C., Lafaille‐Magnan, M., Savard, M., Labonté, A., Breitner, J., Rosa‐Neto, P., Auld, D., Poirier, J., & for the PREVENT‐AD research group
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2019-06-04
Volume
15
Issue
7
Pages
951-960
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2948881719
Cited by
37
References
16
FWCI
3.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation. https://app.cochat.ai/papers/10.1016/j.jalz.2019.03.012
The paper
Miron, J., Picard, C., Lafaille‐Magnan, M., Savard, M., Labonté, A., Breitner, J., Rosa‐Neto, P., Auld, D., Poirier, J., & for the PREVENT‐AD research group. (2019). Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2019.03.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.